JP6313327B2 - 呼吸器系疾患を治療又は予防する方法 - Google Patents

呼吸器系疾患を治療又は予防する方法 Download PDF

Info

Publication number
JP6313327B2
JP6313327B2 JP2015546771A JP2015546771A JP6313327B2 JP 6313327 B2 JP6313327 B2 JP 6313327B2 JP 2015546771 A JP2015546771 A JP 2015546771A JP 2015546771 A JP2015546771 A JP 2015546771A JP 6313327 B2 JP6313327 B2 JP 6313327B2
Authority
JP
Japan
Prior art keywords
cells
stro
cell
asthma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015546771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502980A (ja
JP2016502980A5 (enExample
Inventor
イテシュー、シルビウ
クリシュナン、ラビ
ゴーシュ、ピーター
Original Assignee
メソブラスト、インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メソブラスト、インコーポレイテッド filed Critical メソブラスト、インコーポレイテッド
Publication of JP2016502980A publication Critical patent/JP2016502980A/ja
Publication of JP2016502980A5 publication Critical patent/JP2016502980A5/ja
Application granted granted Critical
Publication of JP6313327B2 publication Critical patent/JP6313327B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2015546771A 2012-12-12 2013-12-12 呼吸器系疾患を治療又は予防する方法 Active JP6313327B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018055386A Division JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法

Publications (3)

Publication Number Publication Date
JP2016502980A JP2016502980A (ja) 2016-02-01
JP2016502980A5 JP2016502980A5 (enExample) 2017-02-02
JP6313327B2 true JP6313327B2 (ja) 2018-04-18

Family

ID=50933587

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015546771A Active JP6313327B2 (ja) 2012-12-12 2013-12-12 呼吸器系疾患を治療又は予防する方法
JP2018055386A Active JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法
JP2020026138A Pending JP2020097618A (ja) 2012-12-12 2020-02-19 呼吸器系疾患を治療又は予防する方法
JP2022024306A Active JP7420844B2 (ja) 2012-12-12 2022-02-18 呼吸器系疾患を治療又は予防する方法
JP2024002878A Pending JP2024041904A (ja) 2012-12-12 2024-01-11 呼吸器系疾患を治療又は予防する方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018055386A Active JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法
JP2020026138A Pending JP2020097618A (ja) 2012-12-12 2020-02-19 呼吸器系疾患を治療又は予防する方法
JP2022024306A Active JP7420844B2 (ja) 2012-12-12 2022-02-18 呼吸器系疾患を治療又は予防する方法
JP2024002878A Pending JP2024041904A (ja) 2012-12-12 2024-01-11 呼吸器系疾患を治療又は予防する方法

Country Status (11)

Country Link
US (3) US10028979B2 (enExample)
EP (1) EP2931373B1 (enExample)
JP (5) JP6313327B2 (enExample)
KR (1) KR101748712B1 (enExample)
CN (2) CN115919901A (enExample)
AU (4) AU2013360026B2 (enExample)
CA (1) CA2893951C (enExample)
ES (1) ES2759281T3 (enExample)
IL (1) IL239309A0 (enExample)
SG (2) SG10201807682PA (enExample)
WO (1) WO2014089625A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
WO2019051536A1 (en) * 2017-09-15 2019-03-21 Cynata Therapeutics Limited METHOD OF TREATING ALLERGIC RESPIRATORY TRACT DISEASE (DAA) / ASTHMA
EP4098267A4 (en) * 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AU2003207399A1 (en) * 2002-02-19 2003-09-09 Medipost Co., Ltd. Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
TR201900968T4 (tr) * 2004-09-24 2019-02-21 Mesoblast Inc Multipotansiyel genleşmiş mezenkimal prekürsör hücre soyu (memp) ve bunların kullanımı.
US8367405B2 (en) * 2005-04-12 2013-02-05 Mesoblast, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
US20120269774A1 (en) 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
CN103169731A (zh) * 2007-08-06 2013-06-26 成血管细胞系统公司 用于体内生成、修复和/或维护结缔组织的方法
ES2595103T3 (es) * 2007-10-17 2016-12-27 Txcell Células Tr1, células madre mesenquimales y usos de estas
SG193888A1 (en) * 2008-09-03 2013-10-30 Mesoblast Inc Expansion of haemopoietic precursors
KR101871472B1 (ko) * 2010-07-02 2018-06-27 메소블라스트, 아이엔씨. 이식편대숙주 질환의 치료 방법
KR102063069B1 (ko) * 2011-03-11 2020-01-08 칠드런'즈 메디컬 센터 코포레이션 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물
EP2714057B1 (en) * 2011-06-03 2019-11-06 Mesoblast, Inc. Methods of treating or preventing neurological diseases
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions

Also Published As

Publication number Publication date
AU2022209219A1 (en) 2022-08-18
AU2022209219B2 (en) 2025-08-14
HK1210077A1 (en) 2016-04-15
US20200289578A1 (en) 2020-09-17
AU2013360026B2 (en) 2018-06-21
EP2931373A4 (en) 2016-05-04
CA2893951C (en) 2022-05-03
KR20150090237A (ko) 2015-08-05
ES2759281T3 (es) 2020-05-08
EP2931373A1 (en) 2015-10-21
CA2893951A1 (en) 2014-06-19
US10028979B2 (en) 2018-07-24
JP2022065132A (ja) 2022-04-26
JP2016502980A (ja) 2016-02-01
JP7420844B2 (ja) 2024-01-23
US10688134B2 (en) 2020-06-23
KR101748712B1 (ko) 2017-06-19
EP2931373B1 (en) 2019-08-21
SG10201807682PA (en) 2018-10-30
JP6665218B2 (ja) 2020-03-13
AU2018226514B2 (en) 2020-01-02
CN105377274A (zh) 2016-03-02
US20150306146A1 (en) 2015-10-29
AU2020202022A1 (en) 2020-04-09
CN115919901A (zh) 2023-04-07
WO2014089625A1 (en) 2014-06-19
SG11201504352TA (en) 2015-07-30
US20190046575A1 (en) 2019-02-14
IL239309A0 (en) 2015-07-30
JP2018118987A (ja) 2018-08-02
JP2020097618A (ja) 2020-06-25
AU2018226514A1 (en) 2018-09-27
JP2024041904A (ja) 2024-03-27
AU2013360026A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
JP7420844B2 (ja) 呼吸器系疾患を治療又は予防する方法
CN103079578B (zh) 治疗移植物抗宿主疾病的方法
JP6184942B2 (ja) 神経疾患を治療するまたは予防する方法
JP2023030116A (ja) 内皮機能不全及び炎症の疾患の治療
AU2016247132B2 (en) Methods for treating obesity and/or metabolic syndrome
US20240024366A1 (en) Methods of treating or preventing respiratory conditions
HK1210077B (en) Methods of treating or preventing respiratory conditions
HK1210209B (en) Treatment of diseases of endothelial dysfunction and inflammation
HK1195488B (en) Methods for treating obesity and/or metabolic syndrome
HK1195488A (en) Methods for treating obesity and/or metabolic syndrome

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150810

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20150810

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20171124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180322

R150 Certificate of patent or registration of utility model

Ref document number: 6313327

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250